Erik A.C. Wiemer

Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump

Herman Burger, Hans van Tol, Antonius W.M. Boersma et al. · Blood · 2004 · 415 citations · Full text

Medicine, Molecular Biology, Oncology +11

Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer

John A. Foekens, Anieta M. Sieuwerts, Marcel Smid et al. · Proceedings of the National Academy of Sciences · 2008 · 367 citations · Full text

Medicine, Cancer Biology, Oncology +17

MicroRNA markers for forensic body fluid identification obtained from microarray screening and quantitative RT-PCR confirmation

Dmitry Zubakov, Anton W. M. Boersma, Ying Choi et al. · International Journal of Legal Medicine · 2010 · 350 citations · Full text

Life Sciences, Molecular Biology, Gene Expression +14

RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.

Herman Burger, John A. Foekens, Maxime P. Look et al. · PubMed · 2003 · 293 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase I Pharmacokinetic and Pharmacodynamic Study of the First-in-Class Spliceosome Inhibitor E7107 in Patients with Advanced Solid Tumors

Ferry A.L.M. Eskens, Francisco Javier Ramos, Herman Burger et al. · Clinical Cancer Research · 2013 · 250 citations · Full text

Medicine, Oncology, Pharmacology +14